Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells (Q40054136)

16 September 2017

title

Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells (English)

1 reference

16 September 2017

Mary S Sakla

1

1 reference

16 September 2017

Nader S Shenouda

2

1 reference

16 September 2017

Pete J Ansell

3

1 reference

16 September 2017

Ruth S Macdonald

4

1 reference

16 September 2017

Dennis B Lubahn

5

1 reference

16 September 2017

publication date

1 August 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

32

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

69-78

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-007-9006-1

16 September 2017

exact match

0 references

cites work

Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12020-007-9006-1

The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma

21 January 2018

1 reference

12 December 2020

Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro

1 reference

12 December 2020

Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells

1 reference

12 December 2020

Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene

1 reference

12 December 2020

Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment

1 reference

12 December 2020

Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein.

1 reference

12 December 2020

Genistein, a specific inhibitor of tyrosine-specific protein kinases

1 reference

12 December 2020

Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor

1 reference

12 December 2020

Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.

1 reference

12 December 2020

AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen

1 reference

12 December 2020

Molecular effects of genistein on estrogen receptor mediated pathways

1 reference

12 December 2020

Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland

1 reference

12 December 2020

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

12 December 2020

20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

1 reference

12 December 2020

Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate

1 reference

12 December 2020

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

1 reference

12 December 2020

Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life.

1 reference

12 December 2020

Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells

1 reference

12 December 2020

Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.

1 reference

12 December 2020

In Vitro and in Vivo Regulation of Antioxidant Response Element-Dependent Gene Expression by Estrogens

1 reference

12 December 2020

Soy for breast cancer survivors: a critical review of the literature

1 reference

12 December 2020

Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells

1 reference

12 December 2020

Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo

1 reference

12 December 2020

Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells

1 reference

12 December 2020

Utilizing prognostic and predictive factors in breast cancer

1 reference

12 December 2020

Relevance of breast cancer cell lines as models for breast tumours: an update

1 reference

12 December 2020

Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells

1 reference

12 December 2020

The basic biology of HER2.

1 reference

12 December 2020

Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation

1 reference

12 December 2020

Estrogen carcinogenesis in breast cancer

1 reference

12 December 2020

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

12 December 2020

Case-control study of phyto-oestrogens and breast cancer

1 reference

12 December 2020

Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells

1 reference

12 December 2020

Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis

1 reference

12 December 2020

Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens.

1 reference

12 December 2020

Repression of cancer protective genes by 17beta-estradiol: ligand-dependent interaction between human Nrf2 and estrogen receptor alpha

1 reference

12 December 2020

Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro

1 reference

12 December 2020

Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells

1 reference

12 December 2020

Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines

1 reference

12 December 2020

Soy isoflavones increase latency of spontaneous mammary tumors in mice

1 reference

12 December 2020

Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis

1 reference

12 December 2020

17 beta-estradiol mimics ligand activity of the c-erbB2 protooncogene product

1 reference

12 December 2020

Cancer statistics, 1996.

1 reference

12 December 2020

Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo

1 reference

12 December 2020

Receptor protein-tyrosine kinases and their signal transduction pathways

1 reference

12 December 2020

Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha

1 reference

12 December 2020

Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha

1 reference

12 December 2020

Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines

1 reference

12 December 2020

Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms

1 reference

12 December 2020

10.1007/S12020-007-9006-1

Identifiers

DOI

1 reference

Dimensions Publication ID

16 September 2017

1051657893

0 references

1 reference